Daniel Loeb's position in Ventyx Biosciences is currently worth $151 Million. That's 3.29% of their equity portfolio (8th largest holding). The investor owns 7.58% of the outstanding Ventyx Biosciences stock. The stake costed the investor $81.7 Million, netting the investor a gain of 84% so far.